SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 29th, 2018 • OncoCyte Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledMarch 29th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 28, 2018, between OncoCyte Corporation, a California corporation (the “Company”), and each purchaser identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).